Document and Entity Information
Document and Entity Information | Aug. 15, 2022 |
Document And Entity Information [Line Items] | |
Entity Address, Address Line Three | 11-12 St. James’s Square |
Amendment Flag | false |
Entity Central Index Key | 0001635088 |
Document Type | 8-K |
Document Period End Date | Aug. 15, 2022 |
Entity Registrant Name | Roivant Sciences Ltd. |
Entity Incorporation State Country Code | D0 |
Entity File Number | 001-40782 |
Entity Tax Identification Number | 98-1173944 |
Entity Address, Address Line One | Suite 1 |
Entity Address, Address Line Two | 3rd Floor |
Entity Address, City or Town | London |
Entity Address, Postal Zip Code | SW1Y 4LB |
Entity Address, Country | GB |
City Area Code | 44 207 |
Local Phone Number | 400 3347 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | true |
Common Stock [Member] | |
Document And Entity Information [Line Items] | |
Security 12b Title | Common Shares, $0.0000000341740141 par value per share |
Trading Symbol | ROIV |
Security Exchange Name | NASDAQ |
Warrant [Member] | |
Document And Entity Information [Line Items] | |
Security 12b Title | Redeemable warrants, each whole warrant exercisable for one Common Share |
Trading Symbol | ROIVW |
Security Exchange Name | NASDAQ |